Clinical Trials Logo

Clinical Trial Summary

The primary purpose of this protocol is to assess the ExAblate 2100 MR guided high intensity focused ultrasound device as an intervention for treatment of facetogenic lower back pain.


Clinical Trial Description

This is a single group, single arm, open/nonblinded, non-randomized study. The primary outcomes are safety and preliminary efficacy. The InSightec ExAblate 2100 MRgHIFU system is a non-invasive thermal ablation device fully integrated with an MR imaging system and used for the ablation of soft tissue and bone.The study will reach primary completion 12 months from the time the study opens to accrual. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02291978
Study type Interventional
Source Stanford University
Contact
Status Withdrawn
Phase N/A
Start date October 2014
Completion date February 20, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT01300715 - An Alternative Technique for Lumbar Medial Branch Radiofrequency: Comparison With the Empirical Technique N/A
Completed NCT03491618 - Analgesic Effect of Different Positions and Canulae on Medial Branch Radiofrequency Denervation for Lumbar Zygapophyseal Joint Pain N/A
Completed NCT02002429 - Medial Branch Blocks vs. Intra-articular Injections: Randomized, Controlled Study N/A
Recruiting NCT05137652 - One-Needle Vs Three-Needle Radiofrequency in Low Back Pain Due to Facet Joint Arthritis N/A
Recruiting NCT01590004 - Technical Description of Cooled Radiofrequency Ablation of Lumbar Medial Branches for the Treatment of Lumbar Facet Pain N/A